XOMA Royalty Corp financial data

Symbol
XOMA, XOMAO, XOMAP on Nasdaq
Industry
Pharmaceutical Preparations
Location
2200 Powell Street, Suite 310, Emeryville, CA
Fiscal year end
December 31
Former names
XOMA Corp (to 7/9/2024), XOMA LTD /DE/ (to 1/17/2012), XOMA CORP /DE/ (to 3/19/1998)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 852 % +63.2%
Debt-to-equity 159 % +943%
Return On Equity -33.7 % -43.4%
Return On Assets -13 % +36.1%
Operating Margin -244 % +61.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.8M shares +2.57%
Common Stock, Shares, Outstanding 11.8M shares +2.46%
Entity Public Float 124M USD -19.9%
Common Stock, Value, Issued 88K USD +2.33%
Weighted Average Number of Shares Outstanding, Basic 11.7M shares +2.08%
Weighted Average Number of Shares Outstanding, Diluted 11.7M shares +2.08%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 21.6M USD +390%
Revenue from Contract with Customer, Excluding Assessed Tax 25K USD -88.9%
Research and Development Expense 2.04M USD +1295%
General and Administrative Expense 34.8M USD +34.1%
Operating Income (Loss) -52.7M USD -87.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -30M USD -12.2%
Earnings Per Share, Basic -3.44 USD/shares -22%
Earnings Per Share, Diluted -3.48 USD/shares -23.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 142M USD +324%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 159M USD +361%
Property, Plant and Equipment, Net 34K USD +580%
Operating Lease, Right-of-Use Asset 335K USD -16.3%
Intangible Assets, Net (Excluding Goodwill) 14.5M USD
Other Assets, Noncurrent 1.93M USD +370%
Assets 223M USD +80%
Accounts Payable, Current 1.13M USD +55.4%
Liabilities, Current 21.1M USD +105%
Operating Lease, Liability, Noncurrent 594K USD
Liabilities 139M USD +664%
Accumulated Other Comprehensive Income (Loss), Net of Tax 104K USD
Retained Earnings (Accumulated Deficit) -1.23B USD -2.49%
Stockholders' Equity Attributable to Parent 84.8M USD -20%
Liabilities and Equity 223M USD +80%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.95M USD -0.47%
Net Cash Provided by (Used in) Financing Activities -4.96M USD -262%
Net Cash Provided by (Used in) Investing Activities -7.25M USD -0.17%
Common Stock, Shares Authorized 277M shares 0%
Common Stock, Shares, Issued 11.8M shares +2.46%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.1M USD -26.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 147M USD +339%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.78M USD
Deferred Tax Assets, Valuation Allowance 58.3M USD +15.9%
Deferred Tax Assets, Gross 58.3M USD +15.9%
Operating Lease, Liability 1.03M USD +157%
Payments to Acquire Property, Plant, and Equipment 17K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -29.9M USD -11.8%
Lessee, Operating Lease, Liability, to be Paid 1.15M USD
Operating Lease, Liability, Current 434K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 300K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 502K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 120K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 91K USD
Deferred Tax Assets, Operating Loss Carryforwards 30.1M USD +25.7%
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 5.9M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 102K USD
Operating Lease, Payments 23K USD -55.8%
Additional Paid in Capital 1.32B USD +0.67%
Amortization of Intangible Assets 897K USD
Share-based Payment Arrangement, Expense 4.34M USD -14.3%
Preferred Stock, Par or Stated Value Per Share 0.05 USD/shares 0%